tetano
Editor, Senior Moderator
Hum Vaccin Immunother
. 2024 Dec 31;20(1):2350817.
doi: 10.1080/21645515.2024.2350817. Epub 2024 May 23. COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population
Narmeen Mallah[SUP] 1 2 3 4 [/SUP], Jacobo Pardo-Seco[SUP] 1 2 5 [/SUP], Irene Rivero-Calle[SUP] 1 2 5 6 [/SUP], Ouhao Zhu-Huang[SUP] 1 2 5 [/SUP], María Fernández Prada[SUP] 7 [/SUP], Catharina Reynen-de Kat[SUP] 8 [/SUP], Oleg Benes[SUP] 8 [/SUP], Liudmila Mosina[SUP] 8 [/SUP], Siddhartha Sankar-Datta[SUP] 8 [/SUP], Olga Aleksinskaya[SUP] 9 [/SUP], David Díaz[SUP] 10 [/SUP], Vusala Allahverdiyeva[SUP] 11 [/SUP], Yevgenii Grechukha[SUP] 11 [/SUP], Tamara Jobava[SUP] 12 [/SUP], Mariia Savchyna[SUP] 11 [/SUP], Pavla Kortusova[SUP] 13 [/SUP], Ioana Novac[SUP] 14 [/SUP], Federico Martinón-Torres[SUP] 1 2 5 6 [/SUP]
Affiliations
COVID-19 vaccine uptake varied across countries, in part due to vaccine hesitancy fueled by a lack of trustworthy information. To help health workers provide evidence-based answers to common questions about COVID-19 vaccines and vaccination, and thereby, assist individuals´ decisions on vaccine acceptance, COVID-19 InfoVaccines, a joint WHO-EU project, was launched in February 2021 to support COVID-19 vaccine rollout in 6 Eastern European countries. COVID-19 InfoVaccines was made available in seven languages and shared on social media networks. A total of 262,592 users accessed COVID-19 InfoVaccines.com between February 11, 2021, and January 31[SUP]st[/SUP], 2023. The users were most interested in: general questions; vaccine efficacy and duration of protection; vaccine safety; vaccine co-administration, and dose-interval and interchangeability; though the interest in a specific theme varied in function of the epidemiological situation. A total of 118,510 (45.1%) and 46,644 (17.7%) users scrolled up to 35% and 75% of the COVID-19 InfoVaccines webpage, respectively. The average engagement rate was 71.61%. The users accessed COVID-19 InfoVaccines from 231 countries and territories, but the majority were in Ukraine (N = 38,404; 14.6%), Spain (N = 23,327; 8.9%), and Argentina (N = 21,167; 8.1%). Older Facebook users were more interested in COVID-19 information than younger individuals (X[SUP]2[/SUP] p-value < .0001). Two hundred twenty-eight videos were shared on YouTube. The average Click-Through-Rate on Facebook was 7.82%, and that on YouTube was 4.4%, with 60 videos having a Click-Through-Rate >5%, falling in the range of average YouTube video Click-Through-Rate (2% - 10%). As misinformation about vaccines and vaccination spreads easily and can negatively impact health-related decisions, initiatives like COVID-19 InfoVaccines are crucial to facilitate access to reliable information.
Keywords: COVID-19; COVID-19 InfoVaccines; Europe; World Health Organization; educational tool; misinformation; vaccine; vaccine hesitancy.
. 2024 Dec 31;20(1):2350817.
doi: 10.1080/21645515.2024.2350817. Epub 2024 May 23. COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population
Narmeen Mallah[SUP] 1 2 3 4 [/SUP], Jacobo Pardo-Seco[SUP] 1 2 5 [/SUP], Irene Rivero-Calle[SUP] 1 2 5 6 [/SUP], Ouhao Zhu-Huang[SUP] 1 2 5 [/SUP], María Fernández Prada[SUP] 7 [/SUP], Catharina Reynen-de Kat[SUP] 8 [/SUP], Oleg Benes[SUP] 8 [/SUP], Liudmila Mosina[SUP] 8 [/SUP], Siddhartha Sankar-Datta[SUP] 8 [/SUP], Olga Aleksinskaya[SUP] 9 [/SUP], David Díaz[SUP] 10 [/SUP], Vusala Allahverdiyeva[SUP] 11 [/SUP], Yevgenii Grechukha[SUP] 11 [/SUP], Tamara Jobava[SUP] 12 [/SUP], Mariia Savchyna[SUP] 11 [/SUP], Pavla Kortusova[SUP] 13 [/SUP], Ioana Novac[SUP] 14 [/SUP], Federico Martinón-Torres[SUP] 1 2 5 6 [/SUP]
Affiliations
- PMID: 38782400
- DOI: 10.1080/21645515.2024.2350817
COVID-19 vaccine uptake varied across countries, in part due to vaccine hesitancy fueled by a lack of trustworthy information. To help health workers provide evidence-based answers to common questions about COVID-19 vaccines and vaccination, and thereby, assist individuals´ decisions on vaccine acceptance, COVID-19 InfoVaccines, a joint WHO-EU project, was launched in February 2021 to support COVID-19 vaccine rollout in 6 Eastern European countries. COVID-19 InfoVaccines was made available in seven languages and shared on social media networks. A total of 262,592 users accessed COVID-19 InfoVaccines.com between February 11, 2021, and January 31[SUP]st[/SUP], 2023. The users were most interested in: general questions; vaccine efficacy and duration of protection; vaccine safety; vaccine co-administration, and dose-interval and interchangeability; though the interest in a specific theme varied in function of the epidemiological situation. A total of 118,510 (45.1%) and 46,644 (17.7%) users scrolled up to 35% and 75% of the COVID-19 InfoVaccines webpage, respectively. The average engagement rate was 71.61%. The users accessed COVID-19 InfoVaccines from 231 countries and territories, but the majority were in Ukraine (N = 38,404; 14.6%), Spain (N = 23,327; 8.9%), and Argentina (N = 21,167; 8.1%). Older Facebook users were more interested in COVID-19 information than younger individuals (X[SUP]2[/SUP] p-value < .0001). Two hundred twenty-eight videos were shared on YouTube. The average Click-Through-Rate on Facebook was 7.82%, and that on YouTube was 4.4%, with 60 videos having a Click-Through-Rate >5%, falling in the range of average YouTube video Click-Through-Rate (2% - 10%). As misinformation about vaccines and vaccination spreads easily and can negatively impact health-related decisions, initiatives like COVID-19 InfoVaccines are crucial to facilitate access to reliable information.
Keywords: COVID-19; COVID-19 InfoVaccines; Europe; World Health Organization; educational tool; misinformation; vaccine; vaccine hesitancy.